PatSnap insights (Pfizer’s Viagra patent expires)
Monday, September 11, 2017
Pfizer recently signed an agreement with Teva Pharmaceuticals, in which Teva can begin to market the US’ first generic version of the drug from December 2017.
Language
Monday, September 11, 2017
Pfizer recently signed an agreement with Teva Pharmaceuticals, in which Teva can begin to market the US’ first generic version of the drug from December 2017.
Category: Article | Category: Video | Category: Whitepaper
Monday, March 13, 2017
The CRISPR/Cas9 gene editing technique has been lauded as one of the most significant advances in medicine, science even, in a generation.
Wednesday, January 11, 2017
Although biotech and pharma both produce drugs, they do so in different ways and have a different basis.